Ca 27-29

It is a form of glycoprotein MUC1.^[2]

References

↑ "Definition of CA 27-29. From MedicineNet. Last Editorial Review: 6/14/2012".
↑ "CA 27-29 in patients with breast cancer with pulmonary fibrosis.". Clin Breast Cancer. 8: 538–40. Dec 2008. doi:10.3816/CBC.2008.n.067. PMID 19073511.

Blood

Endocrine

Thyroid cancer	Thyroglobulin Medullary thyroid cancer (Calcitonin Carcinoembryonic antigen)

Pheochromocytoma	Normetanephrine Enolase 2

Neuroendocrine tumors	Synaptophysin Chromogranin A

Neuroblastoma	Homovanillic acid

Nervous system

Brain tumor	PCNA

Astrocytoma	Glial fibrillary acidic protein

NC/Melanoma	S100 protein Melanoma inhibitory activity

Cardiovascular/
respiratory

Lung cancer	Carcinoembryonic antigen Enolase 2 Autocrine motility factor

Hemangiosarcoma (endothelium)	Factor VIII

Digestive

Colorectal cancer	CA19-9 Carcinoembryonic antigen

Pancreatic cancer	CA19-9 Carcinoembryonic antigen CA 242 Tumor-associated glycoprotein 72

Hepatocellular carcinoma	Alpha-fetoprotein/AFP-L3

Reproductive/
urinary/
breast

Ovarian tumor	Surface epithelial-stromal tumor CA-125 EC CD30 hCG EST Alpha-fetoprotein Choriocarcinoma hCG Dysgerminoma LDH Sertoli-Leydig cell tumour Testosterone GCT Inhibin

Testicular cancer	βhCG Alpha-fetoprotein/AFP-L3 CD30

Prostate cancer	Prostate-specific antigen Prostatic acid phosphatase Glutamate carboxypeptidase II erbB-3 receptor Early prostate cancer antigen-2 SPINK1 GOLM1 PCA3 TMPRSS2

Germ cell tumor	NANOG

Bladder cancer	erbB-3 receptor NMP22

Breast cancer	CA 15-3 erbB-2 receptor erbB-3 receptor Cathepsin D Ca 27-29

General histology

Musculoskeletal

Rhabdomyosarcoma	Desmin

This article is issued from Wikipedia - version of the 3/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.